Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Endocrinol Invest ; 44(11): 2445-2454, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-33738751

RESUMEN

PURPOSE: To investigate predictors of testicular response and non-reproductive outcomes (height, body proportions) after gonadotropin-induced puberty in congenital hypogonadotropic hypogonadism (CHH). DESIGN: A retrospective analysis of the puberty induction in CHH male patients, undergoing an off-label administration of combined gonadotropin (FSH and hCG). METHODS: Clinical and hormonal evaluations before and during gonadotropin stimulation in 19 CHH patients genotyped by Targeted Next Generation Sequencing for CHH genes; 16 patients underwent also semen analysis after gonadotropins. RESULTS: A lesser increase in testicular volume after 24 months of induction was significantly associated with: (I) cryptorchidism; (II) a positive genetic background; (III) a complete form of CHH. We found no significant correlation with the cumulative dose of hCG administered in 24 months. We found no association with the results of semen analyses, probably due to the low numerosity. Measures of body disproportion (eunuchoid habitus and difference between adult and target height: deltaSDSth), were significantly related to the: (I) age at the beginning of puberty induction; (II) duration of growth during the induction; (III) initial bone age. The duration of growth during induction was associated with previous testosterone priming and to partial forms of CHH. CONCLUSIONS: This study shows that a strong genetic background and cryptorchidism, as indicators of a complete GnRH deficiency since intrauterine life, are negative predictors of testicular response to gonadotropin stimulation in CHH. Body disproportion is associated with a delay in treatment and duration of growth during the induction, which is apparently inversely related to previous androgenization.


Asunto(s)
Estatura/efectos de los fármacos , Gonadotropina Coriónica/uso terapéutico , Criptorquidismo , Hormona Folículo Estimulante/uso terapéutico , Predisposición Genética a la Enfermedad , Hipogonadismo , Adulto , Criptorquidismo/diagnóstico , Criptorquidismo/etiología , Relación Dosis-Respuesta a Droga , Disgenesia Gonadal/tratamiento farmacológico , Disgenesia Gonadal/etiología , Gonadotropinas/uso terapéutico , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Humanos , Hipogonadismo/congénito , Hipogonadismo/genética , Hipogonadismo/terapia , Masculino , Pubertad/efectos de los fármacos , Salud Reproductiva/estadística & datos numéricos , Análisis de Semen/métodos , Análisis de Semen/estadística & datos numéricos , Testículo , Tiempo de Tratamiento/normas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...